Dr. David Andrew Riseberg, MD
- Medicare services, 2024
- 37,485
- Medicare patients, 2024
- 1,045
- Part D claims, 2024
- 1,401
- Publications
- 2
- Clinical trials
- 10
- Practice address
- 301 Saint Paul Place, Baltimore, MD 21202
- Practice phone
- Call (410) 332-9237
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Riseberg's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Andrew Riseberg is a medical oncologist in Baltimore, Maryland
Dr. Riseberg practices at Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center.
Dr. Riseberg's NPI, 1124133210, was assigned on August 20, 2006. Dr. Riseberg graduated from University of Maryland School of Medicine in 1989. Dr. Riseberg holds Maryland license D40854.
- NPI
- 1124133210NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9638178684
- NPI enumeration date
- August 20, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (410) 332-9237
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 63
- Medical school graduation
- 1989
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Andrew Riseberg practices at Mercy Medical Center in Baltimore, Maryland
Dr. Riseberg's primary practice is Mercy Medical Center, at 301 Saint Paul Place, Baltimore, MD 21202 in Baltimore City. The practice phone is (410) 332-9237.
- Mercy Medical Center301 Saint Paul Place, Baltimore, MD 21202 · Baltimore CityPhone(410) 332-9237
Source: Dmand AI Affiliation Data
Dr. David Andrew Riseberg is affiliated with 5 sites of care and 2 medical groups
Dr. Riseberg's primary practice is Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center. Dr. Riseberg is also affiliated with University of Maryland Medical Center. The medical group on file is Mercy Personal Physicians Downtown. Dmand AI also links Dr. Riseberg to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. David Andrew Riseberg's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riseberg practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mercy Medical Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mercy Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Andrew Riseberg is one of 157 medical oncologists in Maryland
Medical oncology is Dr. Riseberg's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Riseberg is board certified in hematology by the American Board of Internal Medicine. Dr. Riseberg is licensed in Maryland.
Specialties and state licenses
- Medical oncology, MarylandPrimary
Medical oncologists near Dr. Riseberg
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Andrew Riseberg billed Medicare for 37,485 services in 2024
CMS data shows 37,485 Medicare services from Dr. Riseberg across 33 procedure codes in 2024, for 1,045 Medicare patients. Medicare paid $323,750 for them.
Dr. Riseberg's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 58,6802024: 18,28469%
- Other services
- 2023: 12,2402024: 16,12632%
- Office and hospital visits
- 2023: 1,4902024: 1,4672%
- Tests and treatments
- 2023: 1,5652024: 1,09030%
- Lab and pathology
- 2023: 2632024: 51897%
Where Dr. Riseberg's Medicare services took place, 2024
- In an office36,49097%
- In a facility9953%
Dr. Riseberg compared with the Maryland median for medical oncologists, 2024
- Dr. Riseberg
- Maryland median
- Medicare services
- 37,485vs 42288.8 times
- Medicare patients
- 1,045vs 1437.3 times
- Part D claims
- 1,118vs 1189.5 times
Medians across 124 medical oncologists in Maryland with Dmand AI profiles that report each measure.
Dr. Riseberg's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Riseberg?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Riseberg and other medical oncologists in Maryland.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David Andrew Riseberg treated 1,045 Medicare patients in 2024, average age 74
CMS counts 1,045 Medicare patients who saw Dr. Riseberg in 2024. The largest group is 65 to 74, with 494 patients. 75% of them have cancer, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Riseberg's median patient age at 70, with 85% women.
Dr. Riseberg's Medicare patients by age, 2024
Dr. Riseberg's Medicare patients by sex, 2024
- Women87784%
- Men16816%
Chronic conditions among Dr. Riseberg's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure74%
- Arthritis48%
- Diabetes28%
- Anxiety26%
- Mood disorders25%
- Osteoporosis25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Riseberg's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women85%
- Men14%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David Andrew Riseberg wrote 1,401 Medicare Part D claims in 2024
In 2024, Dr. Riseberg wrote 1,401 Medicare Part D claims for 412 patients. 90% of them were for generic drugs. CMS names the drug for 1,118 of them, across 17 drugs with 11 or more claims each, at $716,275 in total drug cost. In 2023, CMS named 980 claims across 17 drugs.
Dr. Riseberg's Part D claims by kind of drug, 2024
- Generic1,262 claims90%
- Brand-name139 claims10%
Dr. Riseberg's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Riseberg's Part D claims, 2024
- Opioids3%47 of 1,401 claims
- Antibiotics1%20 of 1,401 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9802024: 1,11814%
Drugs named by CMS: 17 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. David Andrew Riseberg scored 79 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Riseberg for performance year 2024, reported as part of a group. Dr. Riseberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Riseberg as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Riseberg's MIPS scores, performance year 2024
- 79of 100Final score
- 56.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David Andrew Riseberg has 2 publications on record
Dmand AI links 2 papers to Dr. Riseberg, published from 2016 to 2017. Dr. Riseberg has published most often in Breast J.
Recent publications by Dr. Riseberg
See who Dr. Riseberg researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Riseberg works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Andrew Riseberg has worked on 10 clinical trials
Dmand AI links Dr. Riseberg to 10 clinical trials, 7 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Neoplasm Metastasis and Neoplastic Processes. National Cancer Institute (NCI) sponsors the most, 4.
Clinical trials with Dr. Riseberg by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Riseberg's trials
- Breast Carcinoma In Situ
- Neoplasm Metastasis
- Neoplastic Processes
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
Investigators on the most trials with Dr. Riseberg
- John T. Cole, MD4 shared trials
- Carlos A. Alemany, MD3 shared trials
- Willard Guy Andrews, MD3 shared trials
Recent clinical trials with Dr. Riseberg
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study (opens in a new tab)
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions (opens in a new tab)
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd (opens in a new tab)
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (opens in a new tab)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Andrew Riseberg received $217,639 in industry payments from 2016 to 2025
CMS Open Payments shows 1,269 general payments to Dr. Riseberg from 88 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $109,210. It also lists 1 research payment totaling $330 in 2025.
General payments to Dr. Riseberg by program year, 2016 to 2025
General payments to Dr. Riseberg by kind, 2016 to 2025
- Speaker and faculty fees$154,63171%
- Food and beverage$30,30014%
- Travel and lodging$19,9519%
- Consulting fees$9,8635%
- Other$2,5441%
Companies that paid Dr. Riseberg the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David Andrew Riseberg graduated from University of Maryland School of Medicine
Dr. Riseberg graduated from University of Maryland School of Medicine in 1989.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. David Andrew Riseberg's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Andrew Riseberg
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Andrew Riseberg's NPI number?
Dr. David Andrew Riseberg's NPI number is 1124133210. It was assigned on August 20, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David Andrew Riseberg?
Dr. David Andrew Riseberg is a medical oncologist in Baltimore, Maryland. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. David Andrew Riseberg practice?
Dr. Riseberg practices at 301 Saint Paul Place, Baltimore, MD 21202. Dr. Riseberg's primary practice is Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center. Dmand AI also links Dr. Riseberg to 1 hospital, 2 group practices and clinics and 1 medical group.
What is Dr. David Andrew Riseberg's office phone number?
The practice phone on file for Dr. Riseberg is (410) 332-9237.
What is Dr. David Andrew Riseberg's medical license number?
Dr. Riseberg holds Maryland license D40854.
Which hospitals is Dr. David Andrew Riseberg affiliated with?
Dr. Riseberg practices at Mercy Medical Center in Baltimore, Maryland. Dr. Riseberg is also affiliated with University of Maryland Medical Center. Dmand AI links Dr. Riseberg to 1 more hospital.
What medical group is Dr. David Andrew Riseberg part of?
Dr. Riseberg is linked to Mercy Personal Physicians Downtown. Dmand AI links Dr. Riseberg to 1 more medical group.
Does Dr. David Andrew Riseberg accept Medicare?
Yes. CMS data shows Dr. Riseberg billed Medicare for 37,485 services in 2024, and Dr. Riseberg accepts Medicare assignment.
Does Dr. David Andrew Riseberg offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Riseberg as offering telehealth services.
What is Dr. David Andrew Riseberg's MIPS score?
Dr. Riseberg's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. David Andrew Riseberg see?
CMS counts 1,045 Medicare patients who saw Dr. Riseberg in 2024, with an average age of 74.
Is Dr. David Andrew Riseberg board certified?
Yes. Dr. Riseberg is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. David Andrew Riseberg bill to Medicare?
In 2024, Dr. Riseberg's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J0881) and injected or infused drug (J0897).
Where did Dr. David Andrew Riseberg go to medical school?
Dr. Riseberg graduated from University of Maryland School of Medicine in 1989.
What drugs does Dr. David Andrew Riseberg prescribe most?
In 2024 Medicare Part D data, Dr. Riseberg's most prescribed drugs by claims were Letrozole, Anastrozole and Gabapentin.
Has Dr. David Andrew Riseberg received payments from drug or device companies?
CMS Open Payments shows $217,639 in general payments to Dr. Riseberg from 88 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. David Andrew Riseberg been practicing?
Dr. Riseberg graduated from medical school in 1989, 37 years ago.
Does Dr. David Andrew Riseberg do research?
Dmand AI links 2 publications to Dr. Riseberg, published from 2016 to 2017. Dr. Riseberg has worked on 10 clinical trials.
Selling to medical oncology practices?
See medical oncologists in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card